Neuritin Promotes Bone Marrow-Derived Mesenchymal Stem Cell Migration to Treat Diabetic Peripheral Neuropathy

Area of Science:

• Biomedical research
• Stem cell biology
• Diabetology

Background:

• Diabetic peripheral neuropathy (DPN) is a common complication of type 2 diabetes.
• Bone marrow mesenchymal stem cells (BMSCs) play a role in nerve repair.
• Neuritin's role in DPN and BMSC migration is not fully understood.

Purpose of the Study:

• To investigate the effect of bone marrow neuritin overexpression on DPN in type 2 diabetic mice (db/db).
• To elucidate the underlying mechanism involving BMSC migration and the SDF-1α/CXCR4-PI3K/Akt pathway.

Main Methods:

• Established bone marrow-specific neuritin overexpression in db/db mice.
• Utilized immunofluorescence, electron microscopy, Oil Red O staining, and transwell migration assays.
• Inhibited the SDF-1α/CXCR4-PI3K/Akt pathway using antagonists in cultured BMSCs.

Main Results:

• Neuritin overexpression ameliorated hyperglycemia and DPN, protecting sciatic nerve structure and function.
• It improved BMSC migration by restoring SDF-1α gradients and activating the SDF-1α/CXCR4-PI3K/Akt pathway.
• Observed reduced fat accumulation, improved vascular/nerve densities, and decreased glutamate levels.

Conclusions:

• Bone marrow neuritin overexpression effectively ameliorates DPN in db/db mice.
• Neuritin enhances BMSC migration through the SDF-1α/CXCR4-PI3K/Akt pathway, contributing to neuropathy repair.
• This highlights a potential therapeutic approach targeting bone marrow-derived stem cells for DPN.